Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongzhou Lu

Showing results (331-340 of 444) with videos related to

Pageof 45
Sort By:
Drug Discoveries & Therapeutics|April 8, 2026
Cytoderm metabolic-labeling SCMLP-TB for pulmonary tuberculosis diagnosis: a preliminary diagnostic accuracy studyGuangyan Liang, Guiqin Dai, Xiaorong Hu, et al.
Pathogens (Basel, Switzerland)|May 4, 2026
Bronchoalveolar Lavage Fluid Cytomegalovirus DNA Load as a Predictor of Mortality in AIDS Patients with Pulmonary Infections: A Retrospective Cohort StudyJunyang Yang, Min Zhang, Renfang Zhang, et al.
Frontiers of Medicine|October 5, 2020
Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infectionYun Tan, Feng Liu, Xiaoguang Xu, et al.
Therapeutic Advances in Respiratory Disease|October 11, 2021
The predictive role of lymphocyte subsets and laboratory measurements in COVID-19 disease: a retrospective studyLin Wang, Jun Chen, Jun Zhao, et al.
Emerging Microbes & Infections|June 24, 2018
Changes in intestinal microbiota in HIV-1-infected subjects following cART initiation: influence of CD4+ T cell countYongjia Ji, Fengdi Zhang, Renfang Zhang, et al.
Nature Communications|August 28, 2024
Evolutionary trajectory and characteristics of Mpox virus in 2023 based on a large-scale genomic surveillance in Shenzhen, ChinaShengjie Zhang, Fuxiang Wang, Yun Peng, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 27, 2022
Utility of urine lipoarabinomannan (LAM) in diagnosing mycobacteria infection among hospitalized HIV-positive patientsDanping Liu, Ling Gu, Renfang Zhang, et al.
Journal of Substance Use|March 26, 2019
Substance use, anxiety, and self-management efficacy in HIV-positive individuals: A mediation analysisWei-Ti Chen, Chengshi Shiu, Joyce P Yang, et al.
American Journal of Infection Control|July 10, 2020
Observations about symptomatic and asymptomatic infections of 494 patients with COVID-19 in Shanghai, ChinaXue Mei, Yuyi Zhang, Hui Zhu, et al.
The Lancet Regional Health. Western Pacific|August 2, 2024
Switch to fixed-dose ainuovirine, lamivudine, and tenofovir DF <i>versus</i> elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed people living with HIV-1: the 48-week results of the SPRINT trial, a multi-centre, randomised, double-blind, active-controlled, phase 3, non-inferiority trialFujie Zhang, Hao Wu, Weiping Cai, et al.
Pageof 45

Showing results (331-340 of 444) with videos related to

Sort By:
Pageof 45
Drug Discoveries & Therapeutics|April 8, 2026
Cytoderm metabolic-labeling SCMLP-TB for pulmonary tuberculosis diagnosis: a preliminary diagnostic accuracy studyGuangyan Liang, Guiqin Dai, Xiaorong Hu, et al.
Pathogens (Basel, Switzerland)|May 4, 2026
Bronchoalveolar Lavage Fluid Cytomegalovirus DNA Load as a Predictor of Mortality in AIDS Patients with Pulmonary Infections: A Retrospective Cohort StudyJunyang Yang, Min Zhang, Renfang Zhang, et al.
Frontiers of Medicine|October 5, 2020
Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infectionYun Tan, Feng Liu, Xiaoguang Xu, et al.
Therapeutic Advances in Respiratory Disease|October 11, 2021
The predictive role of lymphocyte subsets and laboratory measurements in COVID-19 disease: a retrospective studyLin Wang, Jun Chen, Jun Zhao, et al.
Emerging Microbes & Infections|June 24, 2018
Changes in intestinal microbiota in HIV-1-infected subjects following cART initiation: influence of CD4+ T cell countYongjia Ji, Fengdi Zhang, Renfang Zhang, et al.
Nature Communications|August 28, 2024
Evolutionary trajectory and characteristics of Mpox virus in 2023 based on a large-scale genomic surveillance in Shenzhen, ChinaShengjie Zhang, Fuxiang Wang, Yun Peng, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 27, 2022
Utility of urine lipoarabinomannan (LAM) in diagnosing mycobacteria infection among hospitalized HIV-positive patientsDanping Liu, Ling Gu, Renfang Zhang, et al.
Journal of Substance Use|March 26, 2019
Substance use, anxiety, and self-management efficacy in HIV-positive individuals: A mediation analysisWei-Ti Chen, Chengshi Shiu, Joyce P Yang, et al.
American Journal of Infection Control|July 10, 2020
Observations about symptomatic and asymptomatic infections of 494 patients with COVID-19 in Shanghai, ChinaXue Mei, Yuyi Zhang, Hui Zhu, et al.
The Lancet Regional Health. Western Pacific|August 2, 2024
Switch to fixed-dose ainuovirine, lamivudine, and tenofovir DF <i>versus</i> elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed people living with HIV-1: the 48-week results of the SPRINT trial, a multi-centre, randomised, double-blind, active-controlled, phase 3, non-inferiority trialFujie Zhang, Hao Wu, Weiping Cai, et al.
Pageof 45